TLR4 and colorectal carcinoma: Similarly, the Toll‐like receptor 4 (TLR4) signaling pathway contributes to CRC by promoting macrophage activation and infiltration into the colonic mucosa, as well as increasing proinflammatory cytokine expression, fostering an inflammatory microenvironment conducive to tumor development [59].